Operating Lease, Right-of-Use Asset in USD of NEOGENOMICS INC from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Neogenomics Inc quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • Neogenomics Inc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $80.2M, a 1.59% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NEOGENOMICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $80.2M -$1.29M -1.59% 30 Sep 2025 10-Q 28 Oct 2025
Q2 2025 $82.9M -$801K -0.96% 30 Jun 2025 10-Q 29 Jul 2025
Q1 2025 $77.8M -$8.78M -10.1% 31 Mar 2025 10-Q 29 Apr 2025
Q4 2024 $79.6M -$12.2M -13.3% 31 Dec 2024 10-Q 28 Oct 2025
Q3 2024 $81.4M -$5.69M -6.53% 30 Sep 2024 10-Q 05 Nov 2024
Q2 2024 $83.7M -$7.74M -8.47% 30 Jun 2024 10-Q 30 Jul 2024
Q1 2024 $86.6M -$7.21M -7.68% 31 Mar 2024 10-Q 30 Apr 2024
Q4 2023 $91.8M -$4.34M -4.52% 31 Dec 2023 10-K 18 Feb 2025
Q3 2023 $87.1M -$11.8M -11.9% 30 Sep 2023 10-Q 06 Nov 2023
Q2 2023 $91.4M -$8.51M -8.51% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $93.8M -$8.17M -8.01% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $96.1M -$6.09M -5.96% 31 Dec 2022 10-K 20 Feb 2024
Q3 2022 $98.9M -$3.37M -3.29% 30 Sep 2022 10-Q 08 Nov 2022
Q2 2022 $99.9M +$45.4M +83.1% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $102M +$51.1M +100% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $102M +$56.4M +123% 31 Dec 2021 10-K 24 Feb 2023
Q3 2021 $102M +$56.5M +123% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $54.6M +$7M +14.7% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $50.9M +$1.82M +3.71% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $45.8M +$19.3M +72.8% 31 Dec 2020 10-K 25 Feb 2022
Q3 2020 $45.9M +$20.1M +77.8% 30 Sep 2020 10-Q 29 Oct 2020
Q2 2020 $47.6M +$21.5M +82.5% 30 Jun 2020 10-Q 31 Jul 2020
Q1 2020 $49.1M +$29.4M +149% 31 Mar 2020 10-Q 29 Apr 2020
Q4 2019 $26.5M +$16.8M +173% 31 Dec 2019 10-K 25 Feb 2021
Q3 2019 $25.8M 30 Sep 2019 10-Q 13 Nov 2019
Q2 2019 $26.1M 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $19.7M 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $9.7M 01 Jan 2019 10-K 28 Feb 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.